AVITA Medical Inc

NASDAQ:RCELUnited States

AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.

Contact Information

Headquarters

28159 Avenue Stanford, Suite 220VALENCIA, CA, United States 91355

Phone

661-367-9170

Fax

---

Executives

Independent Non-Executive Chairman of the board

Lou Panaccio

President, Chief Executive Officer, Executive Director

James Corbett

Chief Financial Officer

David O'Toole

Chief Legal and Compliance Officer, Corporate Secretary

Nicole Kelsey

Independent Non-Executive Director

Jeremy Cook